The decreased phosphorylation level of JNK suggests that KRAS may inhibit adiponectin expression by regulating JNK and TNF-α, thereby inhibiting adipogenesis under physiological conditions [91] and affecting adipogenesis by regulating insulin resistance [92]. The gene discussed is ADIPOQ; the disease is Insulin resistance.